HRMY
HRMY
NASDAQ · Pharmaceuticals

Harmony Biosciences Holdings

$33.09
+0.62 (+1.91%)
As of Nov 7, 1:40 AM ET ·
Analyst Consensus
Buy
17
Analysts
High
Coverage
Buy 12 71%
Hold 4 24%
Sell 1 6%
Price Target
Analyst Price Target +182.6% upside
Low Target $67.60
Average Target $93.52
High Target $113.52
Current Price $33.09
Current
$33.09
Target
$93.52
$67.60 $93.52 avg $113.52
Scenario Analysis
Bear Case
$67.60
104.3%
Low target
Base Case
$93.52
+182.6%
Avg target
Bull Case
$113.52
+243.1%
High target
Risk/Reward
2.3x
Favorable
Price in Context
52-Week High
$43.49
-23.9% from high
52-Week Low
$25.90
+27.8% from low
50-Day SMA
$39.36
-15.9% vs SMA
200-Day SMA
$34.66
-4.5% vs SMA
RSI (14)
33.6
Neutral
Target vs 52W High
$93.52
+115.0% vs high
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
Strong Buy 36 86% $1,330.33 -1.7%
RDY
Dr. Reddy's Laboratories
Sell 42 45% — +0.0%
JNJ
Johnson & Johnson
Buy 30 73% $299.55 +8.4%
MRK
Merck & Co. Inc.
Buy 35 74% $159.27 +8.5%
PFE
Pfizer Inc.
Hold 33 39% $33.90 +15.3%
BMY
Bristol-Myers Squibb Co
Hold 34 44% $174.50 +180.8%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 14 93% $36.26 -46.1%
ZTS
Zoetis Inc
Hold 23 48% $209.87 +164.3%